OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review
Andri Frediansyah, Fajar Sofyantoro, Saad Alhumaid, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4305-4305
Open Access | Times Cited: 26
Andri Frediansyah, Fajar Sofyantoro, Saad Alhumaid, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4305-4305
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide
Jiawei Zuo, Tao Meng, Yuanyuan Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 641-641
Open Access | Times Cited: 33
Jiawei Zuo, Tao Meng, Yuanyuan Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 641-641
Open Access | Times Cited: 33
Kaempferol: A Review of Current Evidence of Its Antiviral Potential
Argyrios Periferakis, Aristodemos-Theodoros Periferakis, Lamprini Troumpata, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16299-16299
Open Access | Times Cited: 19
Argyrios Periferakis, Aristodemos-Theodoros Periferakis, Lamprini Troumpata, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16299-16299
Open Access | Times Cited: 19
Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
From Archipelago to Pandemic Battleground: Unveiling Indonesia’s COVID-19 Crisis
Biyan Nathanael Harapan, Triswan Harapan, Lenny Theodora, et al.
Journal of Epidemiology and Global Health (2023) Vol. 13, Iss. 4, pp. 591-603
Open Access | Times Cited: 11
Biyan Nathanael Harapan, Triswan Harapan, Lenny Theodora, et al.
Journal of Epidemiology and Global Health (2023) Vol. 13, Iss. 4, pp. 591-603
Open Access | Times Cited: 11
Zebrafish as a model organism for virus disease research: Current status and future directions
Fajar Sofyantoro, Dwi Sendi Priyono, Nur Indah Septriani, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33865-e33865
Open Access | Times Cited: 4
Fajar Sofyantoro, Dwi Sendi Priyono, Nur Indah Septriani, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33865-e33865
Open Access | Times Cited: 4
Secondary metabolites of Alternaria alternate appraisal of their SARS-CoV-2 inhibitory and anti-inflammatory potentials
Fatma A. Moharram, Reham R. Ibrahim, Shahenda Mahgoub, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313616-e0313616
Open Access
Fatma A. Moharram, Reham R. Ibrahim, Shahenda Mahgoub, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313616-e0313616
Open Access
Endophytic fungal derived antivirals: Expanding the armamentarium against emerging pathogens
Palak Rana, Chetna Jhamat, Sahil Jain, et al.
Elsevier eBooks (2025), pp. 327-338
Closed Access
Palak Rana, Chetna Jhamat, Sahil Jain, et al.
Elsevier eBooks (2025), pp. 327-338
Closed Access
Bioactive Molecules of Microbial Origin
Devargya Ganguly, Surajit Sengupta, Sikha Ghosh, et al.
(2025), pp. 17-42
Closed Access
Devargya Ganguly, Surajit Sengupta, Sikha Ghosh, et al.
(2025), pp. 17-42
Closed Access
Therapeutic and Preventive Effects of Natural Compounds Derived from Microbes
Matthew Chidozie Ogwu, Odangowei Inetiminebi Ogidi, Sylvester Chibueze Izah, et al.
Springer eBooks (2025), pp. 1-34
Closed Access
Matthew Chidozie Ogwu, Odangowei Inetiminebi Ogidi, Sylvester Chibueze Izah, et al.
Springer eBooks (2025), pp. 1-34
Closed Access
A review of the use of cyanobacterial metabolites in the treatment of viral and cancer diseases
Bahareh Nowruzi, Fatemeh Bagheri
Deleted Journal (2025) Vol. 35, Iss. 1, pp. 1-13
Closed Access
Bahareh Nowruzi, Fatemeh Bagheri
Deleted Journal (2025) Vol. 35, Iss. 1, pp. 1-13
Closed Access
Unveiling the microbial realm with VEBA 2.0: a modular bioinformatics suite for end-to-end genome-resolved prokaryotic, (micro)eukaryotic and viral multi-omics from either short- or long-read sequencing
Josh L. Espinoza, Allan R. Phillips, Melanie B. Prentice, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 14, pp. e63-e63
Open Access | Times Cited: 3
Josh L. Espinoza, Allan R. Phillips, Melanie B. Prentice, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 14, pp. e63-e63
Open Access | Times Cited: 3
SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19
Hongyu Liang, Yuyan Wu, Vicky Yau, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1538-1538
Open Access | Times Cited: 15
Hongyu Liang, Yuyan Wu, Vicky Yau, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1538-1538
Open Access | Times Cited: 15
A review of immune modulators and immunotherapy in infectious diseases
P. Vijayan, J.G. Xavier, Mohanan Parayanthala Valappil
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 8, pp. 1937-1955
Closed Access | Times Cited: 7
P. Vijayan, J.G. Xavier, Mohanan Parayanthala Valappil
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 8, pp. 1937-1955
Closed Access | Times Cited: 7
Developments in Exploring Fungal Secondary Metabolites as Antiviral Compounds and Advances in HIV-1 Inhibitor Screening Assays
Bruce Nzimande, John P. Makhwitine, Nompumelelo Mkhwanazi, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1039-1039
Open Access | Times Cited: 6
Bruce Nzimande, John P. Makhwitine, Nompumelelo Mkhwanazi, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1039-1039
Open Access | Times Cited: 6
Unveiling the Microbial Realm with VEBA 2.0: A modular bioinformatics suite for end-to-end genome-resolved prokaryotic, (micro)eukaryotic, and viral multi-omics from either short- or long-read sequencing
Josh L. Espinoza, Allan R. Phillips, Melanie B. Prentice, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Josh L. Espinoza, Allan R. Phillips, Melanie B. Prentice, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Natural Product-Based Anti-Viral Agents Against RNA Viruses: An Important Strategy for Pandemic Preparedness
Thrithamarassery Gangadharan Nandu, Jithesh Kottur
(2024), pp. 411-440
Closed Access | Times Cited: 1
Thrithamarassery Gangadharan Nandu, Jithesh Kottur
(2024), pp. 411-440
Closed Access | Times Cited: 1
A novel nano-drug delivery system of glycyrrhetinic acid-mediated intracellular breakable brucine for enhanced anti-hepatitis B efficacy
Qingxia Guan, Yumeng Liu, Zhaorui Xia, et al.
Journal of Biomaterials Applications (2024) Vol. 39, Iss. 2, pp. 150-161
Closed Access | Times Cited: 1
Qingxia Guan, Yumeng Liu, Zhaorui Xia, et al.
Journal of Biomaterials Applications (2024) Vol. 39, Iss. 2, pp. 150-161
Closed Access | Times Cited: 1
Analysis of antioxidant nutrients, anti-HIV and anticancer metabolic fingerprints of Pelargonium quercifolium (L.f) L'Hér
Muhali Olaide Jimoh, Nasifu Kerebba, Olaitan Chinenye Okechukwu, et al.
Food Chemistry Advances (2024) Vol. 5, pp. 100804-100804
Open Access | Times Cited: 1
Muhali Olaide Jimoh, Nasifu Kerebba, Olaitan Chinenye Okechukwu, et al.
Food Chemistry Advances (2024) Vol. 5, pp. 100804-100804
Open Access | Times Cited: 1
In-vitro and in-silico anti-HSV-1 activity of a marine steroid from the jellyfish Cassiopea andromeda venom
Shakib Shamsian, Iraj Nabipour, Gholamhossein Mohebbi, et al.
Microbial Pathogenesis (2023) Vol. 186, pp. 106486-106486
Closed Access | Times Cited: 3
Shakib Shamsian, Iraj Nabipour, Gholamhossein Mohebbi, et al.
Microbial Pathogenesis (2023) Vol. 186, pp. 106486-106486
Closed Access | Times Cited: 3
Natural Products: Exploring Potential Against SARS CoV2
Preetha Nair, Sabu Abdulhameed
(2024), pp. 441-474
Closed Access
Preetha Nair, Sabu Abdulhameed
(2024), pp. 441-474
Closed Access
Evaluating microbial products as potential SARS-CoV-2 inhibitors
Shreynish Joy Mawooa, Hema Bikoo, Yojna Chumrah, et al.
Elsevier eBooks (2024), pp. 265-295
Closed Access
Shreynish Joy Mawooa, Hema Bikoo, Yojna Chumrah, et al.
Elsevier eBooks (2024), pp. 265-295
Closed Access
Spectroscopic Characterization and Biological Effects of 1-Oxo-bisabolone-rich Pulicaria burchardii Hutch. subsp. burchardii Essential Oil Against Viruses, Bacteria, and Spore Germination
Giusy Castagliuolo, Federica Dell’Annunziata, Sara Pio, et al.
Plants (2024) Vol. 14, Iss. 1, pp. 68-68
Open Access
Giusy Castagliuolo, Federica Dell’Annunziata, Sara Pio, et al.
Plants (2024) Vol. 14, Iss. 1, pp. 68-68
Open Access
Targeting the Receptor Binding Domain and Heparan Sulfate Binding for Antiviral Drug Development against SARS-CoV-2 Variants
Zi-Sin Yang, Tzong-Shiun Li, Cheng‐Chung Chang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Zi-Sin Yang, Tzong-Shiun Li, Cheng‐Chung Chang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Aspergillus and Aspergillosis in People with Chronic Diseases
Bismark Dabuo, Nunekpeku Xorlali, Ndego Timothy Amoliga, et al.
Infectious diseases (2023)
Open Access | Times Cited: 1
Bismark Dabuo, Nunekpeku Xorlali, Ndego Timothy Amoliga, et al.
Infectious diseases (2023)
Open Access | Times Cited: 1
Aspergillus and Aspergillosis - Advances in Genomics, Drug Development, Diagnosis and Treatment
Mehdi Razzaghi‐Abyaneh, Mahendra Rai, Masoomeh Shams‐Ghahfarokhi
Infectious diseases (2023)
Open Access
Mehdi Razzaghi‐Abyaneh, Mahendra Rai, Masoomeh Shams‐Ghahfarokhi
Infectious diseases (2023)
Open Access
